Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

More Evidence Linking Sugared Drinks To Diabetes

A new study uncovers some potentially important new details about the association between sugared drinks and diabetes. In a paper published in Diabetologia [pdf], researchers in the UK report on a study of more than 25,000 adults. Over the course of more than 10 years of followup 847 participants went on to develop diabetes. Instead of relying on a […]

Read More »

5 Reasons The Affordable Care Act Will Be Good For Americans

In October, 2013, at the launch of the Affordable Care Act, I predicted that the health insurance exchanges about to go into effect would grow in popularity and  improve the health insurance marketplace, then so imperfect. Twenty months later, the exchanges are proving effective in reducing the number of uninsured and are beginning to provide […]

Read More »

CRISPR: The Technology Behind Human Embryo Editing

The startling research paper detailing the first-ever attempt to edit the genome of human embryos has aroused a great deal of interest and some alarm, but the nature of the DNA editing technique, known as CRISPR, is not so widely known. Also not so widely known is the technique’s peculiar history, which shows again how […]

Read More »

FDA Approves BREO ELLIPTA for the Treatment of Adults With Asthma in the US

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA–(Marketwired – Apr 30, 2015) – GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO® ELLIPTA® (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is […]

Read More »

Gilead first-quarter profit doubles on strong hepatitis C drug sales

(Reuters) – Gilead Sciences Inc on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates. Gilead signaled that, with its hepatitis C franchise established, it is a good time for the company to consider business development opportunities. “We want to stick very […]

Read More »

FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug

(Reuters) – The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said.   The FDA declined to approve Breo for younger asthma sufferers. The agency, in a so-called complete response letter, told the companies […]

Read More »

FDA approves Medicines Co’s blood-clotting agent

(Reuters) – The U.S. Food and Drug Administration on Thursday approved The Medicines Co’s dry powder blood-clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The treatment, Raplixa, is a combination of two human plasma-derived blood-clotting proteins – fibrinogen and thrombin. (1.usa.gov/1HVGQSd) Raplixa is used to control bleeding […]

Read More »

FDA approves the Medicines Co’s pain drug device Ionsys

(Reuters) – The U.S. Food and Drug Administration approved the Medicines Co’s drug device, Ionsys, for postoperative pain for hospital use, the company said on Thursday. Ionsys – a needleless, patient-controlled opioid-based treatment – offers patients recovering from surgery in the hospital control over their analgesic dosing. Ionsys was originally developed by Johnson & Johnson […]

Read More »

FDA approves BREO ELLIPTA for the treatment of adults with asthma in the US

LONDON and SAN FRANCISCO, April 30, 2015 /PRNewswire/ — GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO® ELLIPTA® (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is not indicated for the […]

Read More »

What AMC’s Mad Men Tells Us About Healthcare

One of the striking features of the early episodes of AMC’s hit television show Mad Men is the similarities in the lifestyle enjoyed by the lowest paid members of Don Draper’s advertising company and its wealthy partners. In the show’s 1960s setting, regardless of class, these folks largely lived in similar homes, went to the same […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom